Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Rhythm Pharmaceuticals Launches Hypothalamic Obesity Treatment in Japan

Rhythm Pharmaceuticals Launches Hypothalamic Obesity Treatment in Japan

MT newswireMT newswire2026/10/14 08:32
04:32 AM EDT, 10/14/2026 (MT Newswires) -- Rhythm Pharmaceuticals (RYTM) launched Imcivree in Japan for the treatment of acquired hypothalamic obesity, the company said late Tuesday. Hypothalamic obesity is a rare, serious condition that can result in weight gain and uncontrollable hunger.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share

Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

华尔街见闻•2026/11/21 12:01
Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share